EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

Co-occurrence of schizophrenia and substance use disorders – diagnosis and management. Guidelines from the Expert Group of the Polish Psychiatric Association. Part I. Epidemiology and diagnosis

Agata Szulc, Adam Wichniak, Dominika Dudek, Piotr Gałecki, Napoleon Waszkiewicz, Marcin Wojnar, Jerzy Samochowiec

Psychiatria Polska · 19.10.2026 · 1-15

DOI: 10.12740/pp/onlinefirst/230958 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Psychiatria Polska, online erschienen am 19.10.2026. Verfasst von Agata Szulc und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This article presents the guidelines of the Polish Psychiatric Association regarding the co-occurrence of schizophrenia and substance use disorders (so-called dual diagnosis). This problem affects 40–60% of people with schizophrenia, and the most commonly used substances are nicotine, alcohol, cannabis, and stimulants. The co-occurrence of substance use disorder worsens the course of the illness, increases the number of relapses and hospitalizations, and raises the risk of suicide, violence, homelessness, and social exclusion, while also making it more difficult to adhere to treatment recommendations. The document emphasizes the need for integrated diagnosis, including a clinical interview, toxicological testing, information from family members, and standardized tools such as the SCID, PANSS, BPRS, AUDIT, DUDIT, DAST, and ASSIST. It is particularly important to differentiate schizophrenia from psychoses induced by psychoactive substances. Primary schizophrenia is indicated by the persistence of psychotic symptoms for at least one month after the end of intoxication or substance withdrawal. The guidelines recommend using the ICD-10/11 or DSM-5 criteria and conducting regular, integrated psychiatric and addiction assessments. The authors also point to the need to improve the organization of care and the implementation of comprehensive treatment for patients with dual diagnosis.

Zitieren

APA

Szulc, A., Wichniak, A., Dudek, D., Gałecki, P., Waszkiewicz, N., Wojnar, M., & Samochowiec, J. (2026). Co-occurrence of schizophrenia and substance use disorders – diagnosis and management. Guidelines from the Expert Group of the Polish Psychiatric Association. Part I. Epidemiology and diagnosis. Psychiatria Polska, 1-15. https://doi.org/10.12740/pp/onlinefirst/230958

Vancouver

Szulc A, Wichniak A, Dudek D, Gałecki P, Waszkiewicz N, Wojnar M, et al. Co-occurrence of schizophrenia and substance use disorders – diagnosis and management. Guidelines from the Expert Group of the Polish Psychiatric Association. Part I. Epidemiology and diagnosis. Psychiatria Polska. 2026:1-15. doi:10.12740/pp/onlinefirst/230958

BibTeX
@article{Szulc2026,
  author = {Szulc, Agata and Wichniak, Adam and Dudek, Dominika and Gałecki, Piotr and Waszkiewicz, Napoleon and Wojnar, Marcin and Samochowiec, Jerzy},
  title = {Co-occurrence of schizophrenia and substance use disorders – diagnosis and management. Guidelines from the Expert Group of the Polish Psychiatric Association. Part I. Epidemiology and diagnosis},
  journal = {Psychiatria Polska},
  year = {2026},
  pages = {1--15},
  doi = {10.12740/pp/onlinefirst/230958}
}
Kostenlos starten →